Biotech, Health Services, and Medical Devices Drive August 2025 Healthcare Transactions

In August, healthcare transactions surpassed $32B in disclosed value, led by platform-scale acquisitions and high-growth investments across biotech, health services, and medical devices.

Key Insights:

Strategic Mega-Merger: Mallinckrodt’s $6.7B merger with Endo Pharmaceuticals anchored biotech deal flow.
Home Health Leadership: UnitedHealth’s $3.3B acquisition of Amedisys expanded its continuum of care.
Dermatology Specialty Exit: EQT’s $2.6B secondary sale of Galderma reflected strong demand in skin health.
Innovative Devices: HistoSonics’ $2.3B buyout and Terumo’s $1.5B OrganOx acquisition showcased momentum in non-invasive and transplant-enabling technologies.
Provider Platforms: Cardinal Health’s $1.9B Solaris Health acquisition underscored consolidation in specialty care delivery.

Download the August 2025 Healthcare Transactions Report!

Written By: Dakota Research

Related Content

September 17, 2025 Investor News: Advent Eyes Early '26 Close on $25B+ GPE XI, and more...
September 17, 2025

Biotech, Health Services, and Medical Devices Drive August 2025 Healthcare Transactions
September 17, 2025

August Capital Flows Led by Core Real Estate & AI Infrastructure
September 08, 2025

July 2025 – Healthcare Transactions Remain Strong Across Pharmaceuticals, Biotech, MedTech, Services, and Digital Health
August 26, 2025

The Database For Cold Outreach to Reach Institutional and RIA Investors

Book A Demo

Biotech, Health Services, and Medical Devices Drive August 2025 Healthcare Transactions

Subscribe

Related Content

The Database For Cold Outreach to Reach Institutional and RIA Investors

Address

Products & Services

Resources

Podcasts

Events

Company